NFE2L2 and cancer: However, in later stages of cancer, the constitutive activation of NRF2 promotes cancer progression by protecting cancer cells from the reactive oxygen species (ROS) induced cell death, enabling the detoxification of chemotherapeutics, promoting metabolic re-programming, and suppressing the immune response by reducing inflammation.